Experimental Helicobacter pylori infection in humans: A multifaceted challenge

Gut

Volumn 53, Issue 9, 2004, Pages 1220-1221

  Michetti, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; VIRULENCE FACTOR;

BACTERIAL INFECTION; BACTERIAL TRANSMISSION; DRUG EFFICACY; ETHICS; EXPERIMENTAL INFECTION; EXPERIMENTAL MODEL; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INOCULATION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOM;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ADULT; BACTERIAL VACCINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NONTHERAPEUTIC HUMAN EXPERIMENTATION;

EID: 4344670212     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.042135     Document Type: Note

References (17)

1. Sack DA, Tacket CO, Cohen MB, et al. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun 1998;66:1968-72.
2. Tacket CO, Binion SB, Bostwick E, et al. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 1992;47:276-83.
3. Miller FG, Grady C. The ethical challenge of infection-inducing challenge experiments. Clin Infect Dis 2001;33:1028-33.
4. Marwick C. Volunteers in typhoid infection study will aid future vaccine development. JAMA 1998;279:1423-4.
5. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
6. Rowland M, Kumar D, Daly L, et al. Low rates of Helicobacter pylori reinfection in children. Gastroenterology 1999;117:336-41.
7. Graham DY, Alpert LC, Smith JL, et al. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlornydria. Am J Gastroenterol 1988;83:974-80.
8. Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004;53:1235-43.
9. Tacket CO, Kotloff KL, Losonsky G, et al. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. Am J Trop Med Hyg 1997;56:533-7.
10. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993;11:637-42.
11. Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse/ Helicobacter felis model. Lancet 1992;339:1120-1.
12. Corthésy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995;109:115-21.
13. Keller WC, Michetti P. Vaccination against Helicobacter pylori - an old companion of man. 2001;1:795-802.
14. Ruggiero P, Peppoloni S, Rappuoli R, et al. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? Microbes Infect 2003;5:749-56.
15. Michetti P, Kreiss C, Kotloff KL, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999;116:804-12.
16. Perri F, Qasim A, Marras L, et al. Treatment of Helicobacter pylori infection. Helicobacter 2003;8(suppl 1):53-60.
17. Blaser MJ, Lang D. NIAID Workshop: Development of a Standardized Human Challenge Model for Helicobacter pylori, 1999. http://www.niaid.nih.gov/dmid/ meetings/ HpChallengeMdl.htm.